| Autor: |
Alves Guimarães R; Federal University of Goiás, Goiânia., Lucchese R; Federal University of Goiás, Catalão., Lara Fernandes I; Federal University of Goiás, Catalão., Vera I; Federal University of Goiás, Catalão., Goulart Rodovalho A; Municipal Secretary of Health, Catalão., Alves Guimarães V; Federal University of Goiás, Catalão., Cristina Silva G; Federal University of Goiás, Catalão.; Federal University of Uberlândia, Uberlândia., Lopes de Felipe R; Federal University of Goiás, Catalão.; Triangle University Center, Uberlândia., Alexandre de Castro P; Federal University of Goiás, Catalão., Martins Ferreira P; Federal University of Goiás, Goiânia.; Municipal Secretary of Health, Uruaçu. |
| Jazyk: |
angličtina |
| Zdroj: |
Japanese journal of infectious diseases [Jpn J Infect Dis] 2017 May 24; Vol. 70 (3), pp. 340-346. Date of Electronic Publication: 2016 Jun 30. |
| DOI: |
10.7883/yoken.JJID.2015.490 |
| Abstrakt: |
The objective of this study was to estimate the prevalence of and identify factors associated with lifetime testing for the human immunodeficiency virus (HIV) in non-injection drug users (NIDU). A cross-sectional study was conducted with 323 individuals in clinics for chemical dependency in the state of Goiás in the Central-West region of Brazil. Logistic regression analysis was used to identify factors associated with lifetime HIV testing. Testing for HIV was associated with age, female gender, crack use, history of sexually transmitted infections, acquaintance with people living with HIV/AIDS and/or who had died from AIDS, and history of having received some instruction on HIV/AIDS prevention methods. It was found that only 26.6% reported having access to the HIV rapid test. We concluded determinants for HIV testing must be taken into account when planning prevention and programming strategies. These include the widening of testing coverage among NIDU, educational health actions, establishment of links between sexually transmitted infection prevention services and addiction treatment services, and the use of rapid tests to help people who are in contact with the virus learn about their HIV status, enter treatment, and improve their quality of life. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
